Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Shares Outstanding (Weighted Average): 2009-2025

Historic Shares Outstanding (Weighted Average) for Madrigal Pharmaceuticals (MDGL) over the last 14 years, with Sep 2025 value amounting to $22.3 million.

  • Madrigal Pharmaceuticals' Shares Outstanding (Weighted Average) rose 2.65% to $22.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.3 million, marking a year-over-year increase of 2.65%. This contributed to the annual value of $21.8 million for FY2024, which is 10.47% up from last year.
  • According to the latest figures from Q3 2025, Madrigal Pharmaceuticals' Shares Outstanding (Weighted Average) is $22.3 million, which was up 0.39% from $22.2 million recorded in Q2 2025.
  • In the past 5 years, Madrigal Pharmaceuticals' Shares Outstanding (Weighted Average) ranged from a high of $22.3 million in Q3 2025 and a low of $16.0 million during Q1 2021.
  • Its 3-year average for Shares Outstanding (Weighted Average) is $20.5 million, with a median of $21.3 million in 2024.
  • Data for Madrigal Pharmaceuticals' Shares Outstanding (Weighted Average) shows a peak YoY climbed of 17.55% (in 2024) over the last 5 years.
  • Madrigal Pharmaceuticals' Shares Outstanding (Weighted Average) (Quarterly) stood at $17.1 million in 2021, then climbed by 0.04% to $17.1 million in 2022, then grew by 15.43% to $19.7 million in 2023, then climbed by 10.47% to $21.8 million in 2024, then increased by 2.65% to $22.3 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $22.3 million in Q3 2025, compared to $22.2 million in Q2 2025 and $22.1 million in Q1 2025.